Gsa Capital Partners LLP Graybug Vision, Inc. Put Options Transaction History
Gsa Capital Partners LLP
- $1.32 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding GRAY
# of Institutions
1Shares Held
0Call Options Held
0Put Options Held
0About GRAYBUG VISION, INC.
- Ticker GRAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,517,700
- Market Cap $63.5M
- Description
- Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the t...